Current Advances of Mitochondrial Dysfunction and Cardiovascular Disease and Promising Therapeutic Strategies

被引：10
|
作者：
Xia, Dexiang [1 ]
Liu, Yue [1 ]
Wu, Peng [2 ]
Wei, Dangheng [1 ,3 ]
机构：
[1] Univ South China, Hengyang Med Sch, Hunan Int Sci & Technol Cooperat Base Arterioscler, Inst Cardiovasc Dis,Key Lab Arteriosclerol Hunan P, Hengyang, Peoples R China
[2] Hengyang Maternal & Child Hlth Hosp, Hengyang, Peoples R China
[3] Univ South China, Hengyang 421001, Hunan, Peoples R China
来源：
AMERICAN JOURNAL OF PATHOLOGY | 2023年 / 193卷 / 10期
基金：
中国国家自然科学基金;
关键词：
ELECTRON-TRANSPORT CHAIN; ISCHEMIA-REPERFUSION INJURY; DNA COPY NUMBER; OXIDATIVE STRESS; HEART-FAILURE; DOUBLE-BLIND; MYOCARDIAL-ISCHEMIA; DOWN-REGULATION; KETONE-BODIES; BIOGENESIS;
D O I：
10.1016/j.ajpath.2023.06.013
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Mitochondria are cellular power stations and essential organelles for maintaining cellular homeostasis. Dysfunctional mitochondria have emerged as a key factor in the occurrence and development of car-diovascular disease. This review focuses on advances in the relationship between mitochondrial dysfunction and cardiovascular diseases such as atherosclerosis, heart failure, myocardial ischemia reperfusion injury, and pulmonary arterial hypertension. The clinical value and challenges of mitochondria-targeted strategies, including mitochondria-targeted antioxidants, mitochondrial quality control modulators, mitochondrial function protectors, mitochondrial biogenesis promoters, and recently developed mitochondrial transplants, are also discussed. (Am J Pathol 2023,
引用
收藏
页码：1485 / 1500
页数：16
相关论文
共 50 条
  • [31] Mitochondrial Dysfunction in Neurodegenerative Diseases: Mechanisms and Corresponding Therapeutic Strategies
    Meng, Kai
    Jia, Haocheng
    Hou, Xiaoqing
    Zhu, Ziming
    Lu, Yuguang
    Feng, Yingying
    Feng, Jingwen
    Xia, Yong
    Tan, Rubin
    Cui, Fen
    Yuan, Jinxiang
    BIOMEDICINES, 2025, 13 (02)
  • [32] Standpoints in mitochondrial dysfunction: Underlying mechanisms in search of therapeutic strategies
    Videla, Luis A.
    Mariman, Andrea
    Ramos, Bastian
    Silva, Maria Jose
    Del Campo, Andrea
    MITOCHONDRION, 2022, 63 : 9 - 22
  • [33] Mitochondrial dysfunction in cardiovascular disease: Towards exercise regulation of mitochondrial function
    Li, Kunzhe
    Wan, Bingzhi
    Li, Sujuan
    Chen, Zhixin
    Jia, Hao
    Song, Yinping
    Zhang, Jiamin
    Ju, Wenyu
    Ma, Han
    Wang, Youhua
    FRONTIERS IN PHYSIOLOGY, 2023, 14
  • [34] Therapeutic strategies in diabetes and cardiovascular disease - Preface
    Deedwania, PC
    CARDIOLOGY CLINICS, 2005, 23 (02) : XI - XII
  • [35] The role of mitochondrial dysfunction in cardiovascular disease: a brief review
    Chistiakov, Dimitry A.
    Shkurat, Tatiana P.
    Melnichenko, Alexandra A.
    Grechko, Andrey V.
    Orekhov, Alexander N.
    ANNALS OF MEDICINE, 2018, 50 (02) : 121 - 127
  • [36] Cellular Senescence, Mitochondrial Dysfunction, and Their Link to Cardiovascular Disease
    Camacho-Encina, Maria
    Booth, Laura K.
    Redgrave, Rachael E.
    Folaranmi, Omowumi
    Spyridopoulos, Ioakim
    Richardson, Gavin D.
    CELLS, 2024, 13 (04)
  • [37] Mitochondrial dysfunction in psychiatric morbidity: current evidence and therapeutic prospects
    Toker, Lilach
    Agam, Galila
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 2441 - 2447
  • [38] Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease
    Beal, M. F.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S7 - S7
  • [39] Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease
    Beal, M. Flint
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S189 - S194
  • [40] PVT1 in cardiovascular disease: A promising therapeutic target
    Tang, Shang-Shu
    Li, Heng
    Tang, Chao-Ke
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 366 : 10 - 10
12345